Search Results 211-220 of 16570 for Androgens

1. A Clinical Study Of Ifinatamab Deruxtecan (I-DXd) In People With Metastatic Prostate Cancer (MK-2400-001)

   * Has prostate cancer progression while on androgen deprivation therapy (ADT) (or post bilateral orchiectomy) within 6 months prior to Screening * Has ...

2. Endocrinology News - Medical Professionals - Mayo Clinic

   LC-MS/MS lowers diagnostic thresholds for androgen-producing tumors or pathological hyperandrogenism in women. Liquid chromatography with tandem mass ...

3. Publications - Paula D. Chantigian, M.D. - Mayo Clinic

   Evidence for an androgen receptor in the human placenta. Am J Obstet Gynecol. 1981 May 1; 140(1):8-13. View PubMed; McCormick PD, Razel AJ, Spelsberg TC ...

4. A Study To Evaluate The Effectiveness And Safety Of PANZYGA In Pediatric Patients With Chronic Immune Thrombocytopenia (ITP) - Mayo Clinic

   Administration of long-term anti-prolific agents or attenuated androgen therapy when the dose has NOT been stable during the preceding 2 months and a dosage ...

5. Dutasteride and tamsulosin (oral route) - Mayo Clinic

   Dutasteride and tamsulosin combination is used to treat men who have symptoms of an enlarged prostate gland, which is also known as benign prostatic hyperplasia ...

6. A Randomized, Double-blind, Phase 3 Efficacy Trial Of PROSTVAC-V/F +/- GM-CSF In Men With Asymptomatic Or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer - Mayo Clinic

   Documented progressive disease post surgical castration or during androgen suppression therapy, or during complete androgen blockade therapy and withdrawal.

7. Radiation Therapy With Or Without Apalutamide In Treating Patients With Stage III-IV Prostate Cancer - Mayo Clinic

   The purpose of this study is to determine whether, in men with post-prostatectomy PSA recurrences, salvage radiation therapy (SRT) with enhanced anti-androgen ...

8. Assessment of Vertebral Fracture Risk using VFA and Vertebral Strength Assessment with DXA-Finite Element Analysis in Liver Transplant Recipients in Pre-transplant Period - Mayo Clinic

   Use of other systemic medications that can effect bone remodeling including sex hormone replacement therapy (estrogen or testosterone), calcitonin, androgen ...

9. Publications - John C. Cheville, M.D. - Mayo Clinic

   Detection of androgen receptor (AR) splice variants across diverse prostatic and non-prostatic tumor types using the TruSight Oncology 500 (TSO500) assay.

10. C. Scott Collins, M.D. - Doctors and Medical Staff - Mayo Clinic

    MemberAndrogen Society. 2020 - present. MemberAmerican Society for Men's Health. 2019 - present. MemberIRB Education Committee, Mayo Clinic. 2019 - present.